Eu Ivdr Eu Ivd Class B On The Market ๐Ÿ‡ซ๐Ÿ‡ท France

i-Tracker Ocrelizumab

BIOSYNEX ยท ๐Ÿ‡ซ๐Ÿ‡ท France
Devices (same UDI-DI)
1
Certificates
0
Countries
16
Notified Bodies
0

Basic Information

Primary DI
03532672000202
Basic UDI-DI Code
353267CTO002AV7
Reference
CTO 002-50
Device Types
New device
Regulation
Eu Ivdr
Classification
Eu Ivd Class B
Status
On The Market
Manufacturer
BIOSYNEX

Additional Description

i-Tracker Ocrelizumab is an automated assay intended for the quantitative measurement of Ocrelizumab (anti-CD20 agent) in human serum or plasma samples.

CND Nomenclature Codes

Code Description
W0102080799 AUTOIMMUNE DISEASE TDM - OTHER

Available In Countries

๐Ÿ‡ฆ๐Ÿ‡น Austria ๐Ÿ‡ง๐Ÿ‡ช Belgium ๐Ÿ‡จ๐Ÿ‡พ Cyprus ๐Ÿ‡จ๐Ÿ‡ฟ Czechia ๐Ÿ‡ฉ๐Ÿ‡ช Germany ๐Ÿ‡ช๐Ÿ‡ธ Spain ๐Ÿ‡ซ๐Ÿ‡ท France ๐Ÿ‡ฎ๐Ÿ‡ช Ireland ๐Ÿ‡ฎ๐Ÿ‡น Italy ๐Ÿ‡ฑ๐Ÿ‡ฎ Liechtenstein ๐Ÿ‡ฑ๐Ÿ‡บ Luxembourg ๐Ÿ‡ฒ๐Ÿ‡น Malta ๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands ๐Ÿ‡ต๐Ÿ‡ฑ Poland ๐Ÿ‡ต๐Ÿ‡น Portugal ๐Ÿ‡ธ๐Ÿ‡ช Sweden

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Class B) and regulation (EU IVDR).

View all